Zhen Sun

Zhen Sun

Auto-generated profile, based on publicly available information

Zhen Sun

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Cell Reports
Verified
Journal Article
Open access
CCChi-Yeh Chung
Chi-Yeh Chung
ZSZhen Sun
Zhen Sun
GMGavriel Mullokandov
Gavriel Mullokandov
ABAlmudena Bosch
Almudena Bosch
ZQZulekha A. Qadeer
Zulekha A. Qadeer
EBEmily Bernstein
Emily Bernstein
Chromatin-mediated processes influence the development and progression of breast cancer. Using murine mammary carcinoma-derived tumorspheres as a functional readout for an aggressive breast cancer phenotype, we performed a loss-of-function screen targeting 60 epigenetic regulators. We identified the Polycomb protein Cbx8 as a key regulator of mammary carcinoma both in vitro and in vivo. Accordingly, Cbx8 is overexpressed in human breast cancer and correlates with poor survival. Our genomic analyses revealed that Cbx8 positively regulates Notch signaling by maintaining H3K4me3 levels on Notch-network gene promoters. Ectopic expression of Notch1 partially rescues tumorsphere formation in Cbx8-depleted cells. We find that Cbx8 associates with non-PRC1 complexes containing the H3K4 methyltransferase complex component WDR5, which together regulate Notch gene expression. Thus, our study implicates a key non-canonical role for Cbx8 in promoting breast tumorigenesis.

1 November 2019 in Cancer Cell
Verified
Journal Article
Closed access
ZQZulekha A. Qadeer
Zulekha A. Qadeer
David Valle-GarciaDavid Valle-Garcia
David Valle-Garcia
DHDan Hasson
Dan Hasson
ZSZhen Sun
Zhen Sun
ACApril Cook
April Cook
EBEmily Bernstein
Emily Bernstein

2 April 2019 in Essays in Biochemistry
Verified
Journal Article
Closed access
PDF file
ZSZhen Sun
Zhen Sun
EBEmily Bernstein
Emily Bernstein
The eukaryotic genome is regulated in the context of chromatin. Specialized histones, known as histone variants, incorporate into chromatin to replace their canonical counterparts and represent an important layer of regulation to diversify the structural characteristics and functional outputs of chromatin. MacroH2A is an unusual histone variant with a bulky C-terminal non-histone domain that distinguishes it from all other histones. It is a critical player in stabilizing differentiated cell identity by posing as a barrier to somatic cell reprogramming toward pluripotency and acts as a tumor suppressor in a wide range of cancers. MacroH2A histones are generally regarded as repressive variants that are enriched at the inactive X chromosome (Xi) and broad domains across autosomal chromatin. Recent studies have shed light on to how macroH2A influences transcriptional outputs within distinct genomic contexts and revealed new intriguing molecular functions of macroH2A variants beyond transcriptional regulation. Furthermore, the mechanisms of its mysterious chromatin deposition are beginning to be unraveled, facilitating our understanding of its complex regulation of genome function.

2 January 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
SKSarah H. Kim
Sarah H. Kim
APArnaud Da Cruz Paula
Arnaud Da Cruz Paula
TBThais Basili
Thais Basili
HDHiginio Dopeso
Higinio Dopeso
RBRui Bi
Rui Bi
BWBritta Weigelt
Britta Weigelt
Sclerosing stromal tumor (SST) of the ovary is a rare type of sex cord-stromal tumor (SCST), whose genetic underpinning is currently unknown. Here, using whole-exome, targeted capture and RNA-sequencing, we report recurrent FHL2-GLI2 fusion genes in 65% (17/26) of SSTs and other GLI2 rearrangements in additional 15% (4/26) SSTs, none of which are detected in other types of SCSTs (n = 48) or common cancer types (n = 9,950). The FHL2-GLI2 fusions result in transcriptomic activation of the Sonic Hedgehog (SHH) pathway in SSTs. Expression of the FHL2-GLI2 fusion in vitro leads to the acquisition of phenotypic characteristics of SSTs, increased proliferation, migration and colony formation, and SHH pathway activation. Targeted inhibition of the SHH pathway results in reversal of these oncogenic properties, indicating its role in the pathogenesis of SSTs. Our results demonstrate that the FHL2-GLI2 fusion is likely the oncogenic driver of SSTs, defining a genotypic–phenotypic correlation in ovarian neoplasms.

1 October 2014 in Molecular Cell
Verified
Journal Article
Closed access
JGJulian A. Gingold
Julian A. Gingold
Miguel FidalgoMiguel Fidalgo
Miguel Fidalgo
Diana GuallarDiana Guallar
Diana Guallar
ZLZerlina Lau
Zerlina Lau
ZSZhen Sun
Zhen Sun
JWJianlong Wang
Jianlong Wang

5 October 2018 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
ZSZhen Sun
Zhen Sun
DFDan Filipescu
Dan Filipescu
JAJoshua Andrade
Joshua Andrade
AGAlexandre Gaspar-Maia
Alexandre Gaspar-Maia
BUBeatrix Ueberheide
Beatrix Ueberheide
EBEmily Bernstein
Emily Bernstein